Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08)
This study evaluated the real-world effectiveness of nivolumab monotherapy in previously treated advanced gastric cancer. A preplanned 2-year final analysi